Amygdala Neurosciences

Amygdala Neurosciences

Amygdala Neurosciences

A Biopharmaceutical Company Focused on the Developing and Commercializing FirstInClass Therapy for Addiction Disorders
Founded
2015
Raised
$1.4M
Follow us
Twitter followers
Latest funding
$1,350,000
Grant - 2019
National Institutes of Health
Team Size
1–10
Employees
the home of AI info

Amygdala Neurosciences $5.59 million Financing. Alan C Mendelson Published Nov 25 Form D

FinSMEs

Amygdala Neurosciences Raises $5.6M in Financing

the home of AI info

Amygdala Neurosciences Announces $5.6M Financing and Dr. Mack Mitchell's Expanded Role as ...

$1,350,000 Grant
the home of AI info

Amygdala Neurosciences Awarded $1.35 million NIH Grant to Conduct Long Term, Phase 3 ...